BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19828471)

  • 41. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
    Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
    Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Humoral immune responses to testis antigens in sera from patients with prostate cancer.
    Hoeppner LH; Dubovsky JA; Dunphy EJ; McNeel DG
    Cancer Immun; 2006 Jan; 6():1. PubMed ID: 16401063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing.
    Zhou J; Belov L; Huang PY; Shin JS; Solomon MJ; Chapuis PH; Bokey L; Chan C; Clarke C; Clarke SJ; Christopherson RI
    J Immunol Methods; 2010 Apr; 355(1-2):40-51. PubMed ID: 20156443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
    Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
    Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
    Dubovsky JA; McNeel DG
    Prostate; 2007 Dec; 67(16):1781-90. PubMed ID: 17929270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patients with sporadic colorectal cancer or advanced adenomatous polyp have elevated anti-JC virus antibody titer in comparison with healthy controls: a cross-sectional study.
    Niv Y; Vilkin A; Levi Z
    J Clin Gastroenterol; 2010 Aug; 44(7):489-94. PubMed ID: 20421810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological immune response to cancer testis antigens in patients with pancreatic cancer.
    Wadle A; Kubuschok B; Imig J; Wuellner B; Wittig C; Zwick C; Mischo A; Waetzig K; Romeike BF; Lindemann W; Schilling M; Pfreundschuh M; Renner C
    Int J Cancer; 2006 Jul; 119(1):117-25. PubMed ID: 16432832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma.
    Roovers RC; van der Linden E; de Bruïne AP; Arends JW; Hoogenboom HR
    Eur J Cancer; 2001 Mar; 37(4):542-9. PubMed ID: 11267865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic profiling of circulating plasma RNA for the analysis of cancer.
    Collado M; Garcia V; Garcia JM; Alonso I; Lombardia L; Diaz-Uriarte R; Fernández LA; Zaballos A; Bonilla F; Serrano M
    Clin Chem; 2007 Oct; 53(10):1860-3. PubMed ID: 17717129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
    Comtesse N; Zippel A; Walle S; Monz D; Backes C; Fischer U; Mayer J; Ludwig N; Hildebrandt A; Keller A; Steudel WI; Lenhof HP; Meese E
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9601-6. PubMed ID: 15983380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity.
    Bouwman K; Qiu J; Zhou H; Schotanus M; Mangold LA; Vogt R; Erlandson E; Trenkle J; Partin AW; Misek D; Omenn GS; Haab BB; Hanash S
    Proteomics; 2003 Nov; 3(11):2200-7. PubMed ID: 14595819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma.
    Zhao F; Vermeer B; Lehmann U; Kreipe H; Manns MP; Korangy F; Greten TF
    Immunology; 2009 Sep; 128(1):134-40. PubMed ID: 19689742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosignature system for diagnosis of cancer.
    Stafford P; Cichacz Z; Woodbury NW; Johnston SA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3072-80. PubMed ID: 25024171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.
    O'Reilly JA; Fitzgerald J; Fitzgerald S; Kenny D; Kay EW; O'Kennedy R; Kijanka GS
    PLoS One; 2015; 10(4):e0123469. PubMed ID: 25875936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients.
    Fitzgerald S; Sheehan KM; O'Grady A; Kenny D; O'Kennedy R; Kay EW; Kijanka GS
    J Gastroenterol Hepatol; 2013 Jun; 28(6):967-74. PubMed ID: 23425061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delta- like ligand 4- expressing macrophages and human diseases: Insights into pathophysiology and therapeutic opportunities.
    Yuwen Y; Wang X; Liu J; Liu Z; Zhu H
    Heliyon; 2023 Oct; 9(10):e20777. PubMed ID: 37842562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells.
    Afrin F; Mateen S; Oman J; Lai JCK; Barrott JJ; Pashikanti S
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.